Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury: Laboratory investigation

Journal of Neurosurgery: Pediatrics

Volumn 6, Issue 3, 2010, Pages 206-221

  Mazur, Marcus ^a   Miller, Robert H ^a   Robinson, Shenandoah ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

aminobutyric acid; Cerebral palsy; Epilepsy; Erythropoietin receptor; Oligodendrocyte; Preterm brain injury

Indexed keywords

ERYTHROPOIETIN RECEPTOR; PENTETRAZOLE; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; ERYTHROPOIETIN; LIGAND; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL POPULATION; CELL SURVIVAL; EMBRYO; HISTOPATHOLOGY; INTERNEURON; MOTOR PERFORMANCE; NEURAL CELL LOSS; NEUROLOGIC DISEASE; NONHUMAN; OLIGODENDROGLIA; PREMATURITY; PRENATAL DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTEMIC PRENTAL HYPOXIC ISCHEMIC INJURY; THIRD TRIMESTER PREGNANCY; UPREGULATION; ANIMAL; CELL DEATH; CHEMISTRY; DRUG EFFECTS; FETUS DISEASE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SEIZURE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FETAL DISEASES; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; LIGANDS; MOTOR SKILLS; NEURONS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; SEIZURES; RECOMBINANT PROTEINS;

EID: 77956642516     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2010.5.PEDS1032     Document Type: Article

References (62)

1. Anderson J, Sandhir R, Hamilton ES, Berman NE: Impaired expression of neuroprotective molecules in the HIF-1alpha pathway following traumatic brain injury in aged mice. J Neurotrauma 26:1557-1566, 2009
2. Arrieta O, Palencia G, García-Arenas G, Morales-Espinosa D, Hernández-Pedro N, Sotelo J: Prolonged exposure to lead lowers the threshold of pentylenetetrazole-induced seizures in rats. Epilepsia 46:1599-1602, 2005 (Pubitemid 44921933)
3. Aydin A, Genç K, Akhisaroglu M, Yorukoglu K, Gokmen N, Gonullu E: Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 25:494-498, 2003 (Pubitemid 37485656)
4. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC: Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 61:197-211, 2002
5. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, et al: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651, 1999 (Pubitemid 30161216)
6. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97:10526-10531, 2000
7. Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZS, Mc-Quillen PS, et al: Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 58:106-111, 2005 (Pubitemid 40967438)
8. Chavez JC, Baranova O, Lin J, Pichiule P: The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471-9481, 2006 (Pubitemid 44396860)
9. Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X: Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett 425:177-182, 2007 (Pubitemid 47418362)
10. Chen ZY, Asavaritikrai P, Prchal JT, Noguchi CT: Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 282:25875-25883, 2007 (Pubitemid 47372832)
11. Daw MI, Ashby MC, Isaac JT: Coordinated developmental recruitment of latent fast spiking interneurons in layer IV barrel cortex. Nat Neurosci 10:453-461, 2007
12. Demers EJ, McPherson RJ, Juul SE: Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58:297-301, 2005
13. Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641-647, 2001 (Pubitemid 32772276)
14. Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA: Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci U S A 101:9855-9860, 2004 (Pubitemid 38869326)
15. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-421, 1996
16. Fauchère J-C, Dame C, Vonthein R, Koller B, Arri S, Wolf M, et al: An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 122:375-382, 2008
17. Golan H, Huleihel M: The effect of prenatal hypoxia on brain development: short- and long-term consequences demonstrated in rodent models. Dev Sci 9:338-349, 2006 (Pubitemid 43855813)
18. Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, et al: Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29:321-330, 2007 (Pubitemid 47343686)
19. Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, Andreias L, et al: Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA 294:318-325, 2005 (Pubitemid 41043775)
20. Iai M, Takashima S: Thalamocortical development of parvalbumin neurons in normal and periventricular leukomalacia brains. Neuropediatrics 30:14-18, 1999 (Pubitemid 29161089)
21. Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, et al: Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99:10659-10664, 2002
22. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE: A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 122:383-391, 2008
23. Juul SE, Stallings SA, Christensen RD: Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 46:543-547, 1999
24. Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, et al: Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis 24:357-366, 2006 (Pubitemid 44592570)
25. Knabe W, Knerlich F, Washausen S, Kietzmann T, Sirén AL, Brunnett G, et al: Expression patterns of erythropoietin and its receptor in the developing midbrain. Anat Embryol (Berl) 207:503-512, 2004
26. Knabe W, Sirén AL, Ehrenreich H, Kuhn HJ: Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) 210:209-219, 2005
27. Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, et al: Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 83:224-228, 2003 (Pubitemid 36351232)
28. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, et al: Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 153:77-86, 2004 (Pubitemid 38829291)
29. Li Y, Lu Z, Keogh C, Yu SP, Wei L: Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blow flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27:1043-1054, 2007 (Pubitemid 46659037)
30. Liao ZB, Zhi XG, Shi QH, He ZH: Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol 15:140-149, 2008
31. Liu C, Shen K, Liu Z, Noguchi CT: Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272:32395-32400, 1997 (Pubitemid 28011922)
32. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, et al: Births: final data for 2005. Natl Vital Stat Rep 56:1-103, 2007
33. McPherson RJ, Demers EJ, Juul SE: Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 91:36-43, 2007
34. McPherson RJ, Juul SE: Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci 26:103-111, 2008
35. Metz GA, Whishaw IQ: Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and coordination. J Neurosci Methods 115:169-179, 2002
36. Mizuno K, Hida H, Masuda T, Nishino H, Togari H: Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model. Neonatology 94:255-266, 2008
37. Nakajima W, Ishida A, Lange MS, Gabrielson KL, Wilson MA, Martin LJ, et al: Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 20:7994-8004, 2000
38. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 4. San Diego: Academic Press, 1998
39. Petrou S: The economic consequences of preterm birth during the first 10 years of life. BJOG 112 (Suppl 1):10-15, 2005
40. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45, 2001
41. Rabie T, Marti HH: Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) 23:263-274, 2008
42. Robinson S: Systemic prenatal insults disrupt telencephalon development: implications for potential interventions. Epilepsy Behav 7:345-363, 2005
43. Robinson S, Li Q, Dechant A, Cohen ML: Neonatal loss of γ-amino butyric acid pathway expression after human perinatal brain injury. J Neurosurg 104 (6 Suppl):396-408, 2006
44. Robinson S, Petelenz K, Li Q, Cohen ML, Dechant A, Tabrizi N, et al: Developmental changes induced by graded prenatal hypoxic-ischemic insults in rats. Neurobiol Dis 18:568-581, 2005 (Pubitemid 40332715)
45. Ronen GM, Buckley D, Penny S, Streiner DL: Long-term prognosis in children with neonatal seizures: a population-based study. Neurology 69:1816-1822, 2007
46. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al: Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98:4044-4049, 2001 (Pubitemid 32249895)
47. Sirén AL, Knerlich F, Poser W, Gleiter CH, Brück W, Ehrenreich H: Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 101:271-276, 2001 (Pubitemid 32219761)
48. Sizonenko SV, Kiss JZ, Inder T, Gluckman PD, Williams CE: Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatr Res 57:865-872, 2005 (Pubitemid 40727119)
49. Solaroglu I, Solaroglu A, Kaptanoglu E, Dede S, Haberal A, Beskonakli E, et al: Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19:19-22, 2003 (Pubitemid 36798745)
50. Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, et al: Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 1045:22-30, 2005 (Pubitemid 40725216)
51. Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE: Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 61:671-675, 2007 (Pubitemid 46800274)
52. Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, et al: TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci U S A 105:6185-6190, 2008 (Pubitemid 351758420)
53. Trollmann R, Strasser K, Keller S, Antoniou X, Grenacher B, Ogunshola OO, et al: Placental HIFs as markers of cerebral hypoxic distress in fetal mice. Am J Physiol Regul Integr Comp Physiol 295:R1973-R1981, 2008
54. Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, et al: A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26:1269-1274, 2006 (Pubitemid 43237059)
55. Uzüm G, Sarper Diler A, Bahçekapili N, Ziya Ziylan Y: Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci 78:2571-2576, 2006 (Pubitemid 44313776)
56. Vitellaro-Zuccarello L, Mazzetti S, Madaschi L, Bosisio P, Gorio A, De Biasi S: Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience 144:865-877, 2007 (Pubitemid 46013988)
57. Volpe JJ: Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 8:110-124, 2009
58. Volpe JJ: Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 116:221-225, 2005
59. Wen TC, Rogido M, Genetta T, Sola A: Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neurosci Lett 355:165-168, 2004 (Pubitemid 38368729)
60. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M: Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 115:997-1003, 2005
61. Xenocostas A, Cheung WK, Farrell F, Zakszewski C, Kelley M, Lutynski A, et al: The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61:189-195, 2005 (Pubitemid 40768551)
62. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, et al: Erythropoietin receptor signalling is required for normal brain development. Development 129:505-516, 2002 (Pubitemid 34863815)